Search

everythinglearnresearchcommunity

for

Search:↓

Combined oral contraceptives and antiandrogens are effective for treating PCOS symptoms in older women.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

New methods for identifying and managing polycystic ovary syndrome in teenagers are improving.

The entry showed that PCOS negatively affects women's self-image and is worsened by societal expectations, suggesting a need for more feminist attention to the condition.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.

Effective management of PCOS includes lifestyle changes, medication for menstrual regulation, fertility treatments, and cosmetic issue remedies.

PCOS is often caused by hormonal imbalances that can lead to various health issues and may indicate a risk for future metabolic and cardiovascular problems.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

PCOS involves genetic and immune factors, especially T cells, affecting its development.

Girls with Pilonidal Disease are more likely to have Polycystic Ovarian Syndrome, and treating PCOS may reduce the need for PD intervention.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

PCOS is a hormonal disorder in women that can cause infertility and increases the risk of heart and metabolic issues.

PCOS often causes skin problems due to hormonal and metabolic imbalances.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

ILC1-like cells can cause alopecia areata by themselves.

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

The CTLA-4 gene change studied does not affect Polycystic Ovarian Syndrome in the women tested.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

6.1% of patients seeking PRP for hair loss had undiagnosed cicatricial alopecia, which PRP cannot treat.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

Only 22% of teenage girls in the study knew about PCOS, despite many having symptoms.

Many women with polycystic ovarian disease show symptoms like excessive hair growth, acne, hair loss, and have high levels of certain hormones.

Platycladi Cacumen may help treat hair loss by targeting specific proteins and pathways.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.